Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Diagnostics Firm CEOs
GEN recently published a list of the top 10 highest-paid CEOs of diagnostics companies. One thing we noticed while compiling the list was that diagnostics CEOs generally don’t get paid as much as their drug discovery and tools/tech counterparts. What are your thoughts on what these company leaders are paid?